logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
D

Diabetology & Metabolic Syndrome

IF3.9
Papers241
Citations
Journal Papers 236
Publication Date
delete
Short-term semaglutide exposure is associated with increased osteoblast-covered surface in male Swiss mice: a histomorphometric exploratory study
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-10-12
delete0
deleteOAAI
deleteRosângela Roginski Réa; Rafaela Ceron; Kauê Marcel de Oliveira; Rafaella Stradiotto Bernardelli; Marcia Olandoski; Vicente Florentino Castaldo Andrade; Victoria Zeghbi Cochenski Borba; Alexandra Acco; Carolina Aguiar Moreira
deleteShare
deleteSave
Data-driven clinical phenotypes of diabetic kidney disease and their association with disease progression: a real-world cohort study
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-10-11
delete0
deleteOAAI
deleteJiamin He; Jingyuan Ma; Huizhu Qu; Yuancong Li; Dingyun You; Wenxing Fan
deleteShare
deleteSave
Association between glycemic management during pregnancy and postpartum metabolic health outcomes among women with gestational diabetes mellitus
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-10-11
delete0
deleteOAAI
deleteTianli Zhu; Yujie Dong; Le Wang; Ziwei Ding; Lanfang Zhao; Tuyan Fan; Jingjing Liu; Hui Gao; Shuangqin Yan; Xiaomin Jia; Fengyu Yang; Jiawen Ren; Liwen Chen; Fangbiao Tao; Beibei Zhu
deleteShare
deleteSave
Higher ultrasound-derived fat fraction is associated with poor glycemic control in type 2 diabetes mellitus
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-10-10
delete0
deleteOAAI
deleteLulu Sun; Ling Wang; Danlei Song; Pingping Wang; Jiahao Han; Jia Li
deleteShare
deleteSave
The relationship of endothelial cell-specific molecule-1, leptin, and omentin-1 with cardiovascular risk in patients with type 2 diabetes
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-10-08
delete0
deleteOAAI
deleteAleksandra Klisic; Zala Jenko Pražnikar; Saša Kenig; Darko Radinovic; Amina Sahmanovic; Nemanja Petrovic; Jelena Kotur-Stevuljevic; Ana Petelin
deleteShare
deleteSave
Tracking the obesity epidemic: a comprehensive population-based epidemiological assessment of obesity prevalence and its cardiovascular-kidney-metabolic complications
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-10-08
delete0
deleteOAAI
deleteNatalia Zieleniewska; Jacek Jamiołkowski; Paweł Sowa; Irina Kowalska; Marlena Dubatówka; Małgorzata Chlabicz; Zofia Stachurska; Urszula Roszkowska; Karol Kamiński
deleteShare
deleteSave
Associations between glucagon-like peptide-1 receptor agonist use and sensitivity to thyroid hormones in type 2 diabetes mellitus adults: a cross-sectional study
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-10-03
delete0
deleteOAAI
deleteYongping Liu; Ningyu Cai; Ping Feng; Ying Song; Chao Zheng; Mengdie Chen
deleteShare
deleteSave
Controlled attenuation parameter (CAP) shows a more robust association with insulin clearance index than liver stiffness measurement (LSM) in type 2 diabetes mellitus: a retrospective cross-sectional study
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-10-01
delete0
deleteOAAI
deleteYue Li; Xiao Wang; Zhenzhen Fu; Yingyun Gong; Hongwen Zhou
deleteShare
deleteSave
Longitudinal trajectories of estimated glucose disposal rate and risk of incident type 2 diabetes in Chinese adults: a prospective community-based cohort study
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-30
delete0
deleteOAAI
deleteXuanning Luo; Jin Hu; Kewen Liu; Jiaxuan Lan; Weijun Liao; Qingfeng Wu
deleteShare
deleteSave
Opposing Drug Effects on Magnesium and Micronutrient Status in Type 2 Diabetes and their Relation to Cardiovascular Risk: Proton Pump Inhibitors, SGLT2 Inhibitors, Diuretics and Metformin: A scoping review
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-30
delete0
deleteOAAI
deleteDarshan Hullon; Abiya Ahad; Zahra Oskouyan; Tanya Singh; Jeel Padaria
deleteShare
deleteSave
Development and temporal validation of the cardiovascular-kidney-metabolic syndrome four-biomarker score (CKM-BS4): a stage-stratified score for all-cause and cardiovascular mortality across CKM stages in a population-based cohort with linked mortality
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-29
delete0
deleteOAAI
deleteWansheng Lin; Daqian Gu; Ming Shen; Na Zhao; Zhurong Luo; Yi Lin; Meixian Chen
deleteShare
deleteSave
Editorial Expression of Concern: Neuroprotective effect of resveratrol in diabetic cerebral ischemic-reperfused rats through regulation of inflammatory and apoptotic events
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-28
delete0
deleteOAAI
deleteHoda E. Mohamed; Sahar E. El-Swefy; Rehab A. Hasan; Ahmed A. Hasan
deleteShare
deleteSave
Diabetes technology in type 2 diabetes care
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-24
delete0
deleteOAAI
deleteEmir Muzurović; Pratik Choudhary; Špela Volčanšek; Ivana Kraljević; Julia K. Mader; Ksenija Zečević; Stefano Del Prato; Chantal Mathieu
deleteShare
deleteSave
Trends and projected inequalities in type 2 diabetes mellitus mortality in the United States, 1999–2025, with projections to 2035: A CDC WONDER multiple cause of death analysis
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-23
delete0
deleteOAAI
deleteEshal Atif; Abdal Ahmad; Mazhar Ali; Mohib Ali Hassan; Vishan Das; Danyal Ahmad; Kaneez Fatima; Muhammad Mukhlis; Mohammad Dawar Zahid; Sadia Qazi; Muhammad Atif Mazhar; Akef Obeidat
deleteShare
deleteSave
Obstructive sleep apnea shares a common genetic liability with type 2 diabetes, hypertension, and adiposity: a multivariate genome-wide association study
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-23
delete0
deleteOAAI
deleteChung-Chih Liao; Ke-Ru Liao; Jung-Miao Li
deleteShare
deleteSave
Circulating lipocalin-2 as a potential biomarker for MASLD: a systematic review and meta-analysis
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-22
delete0
deleteOAAI
deleteReza Mohammadpour Fard; Elham Akrami; Mohammad Shahmansouri; Negar Sadat Sherafat; Mohammad Rashno; Parnaz Faraji; Seyed Sobhan Bahreiny
deleteShare
deleteSave
Incident ocular outcomes with tirzepatide versus GLP-1 receptor agonists and conventional therapies in diabetes and obesity: a retrospective cohort study from a global federated health research network
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-22
delete0
deleteOAAI
deleteNguyen Ngoc Khoi Truong; Chia-Te Liao; Chih-Wei Chen; Yi-Cheng Lin; Chun-Yao Huang; Chung-Lieh Hung; Jong-Shiuan Yeh; Yu-Hsuan Joni Shao; Gregory Y. H. Lip; Chien-Yi Hsu
deleteShare
deleteSave
Osteoprotegerin lowers type 2 diabetes risk: insights from drug-target Mendelian randomization and mediation analysis
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-18
delete0
deleteOAAI
deleteHeejung Ha; Woo Vin Lee; Yijin An; In-Wha Kim; Jung Mi Oh
deleteShare
deleteSave
Altered relative GLP-1 response patterns in gestational diabetes mellitus: a matched nested case-control study
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-13
delete0
deleteOAAI
deleteYangying Wu; Ping Luo; Keying Qin; Zicong Lin; Yang Yang; Xiaoru Gao; Bing Mei
deleteShare
deleteSave
Cumulative average metabolic indices and cardiovascular disease risk: additive predictive effects and partial mediating role of intrinsic capacity in early-stage CKM syndrome
deleteDiabetology & Metabolic Syndrome
IF3.9
delete2026-09-12
delete0
deleteOAAI
deleteYonghuan Wang; Zhenhua Li; Weijia Zhang; Rui Yan; Min Guo
deleteShare
deleteSave